blossomact.bsky.social @blossomact.bsky.social · 07/04/2025In just over a week, I'll be joining Breaking Convention again. It's the most fun conference in the space, and I'm looking forward to seeing you all there. Get a 10% discount with code BLOSSOM10 021
blossomact.bsky.social @blossomact.bsky.social · 25/03/2025I'm excited—and frankly, a little nervous—to share something we've been working on for the last 6 months: our new report on reimbursement pathways for psychedelic therapies in Europe supported by Norrsken Mind. Access the report here: psychedelicsandreimbursement.compsychedelicsandreimbursement.comPsychedelics and ReimbursementPsychedelics and Reimbursement 110
blossomact.bsky.social @blossomact.bsky.social · 19/12/2024This systematic review (s=45) on psychedelic-assisted psychotherapy for mental disorders finds that psychological interventions are reported with low completeness and high heterogeneity. It also finds that MDMA studies are more homogeneous, with greater procedural detail. blossomanalysis.co… 010
blossomact.bsky.social @blossomact.bsky.social · 05/12/2024In November, 115 new psychedelic research articles were published. In the monthly recap for Blossom, we group and highlight 19 studies that have moved the field forward. From challenging experiences to the health economics of MDMA 👇 blossomanalysis.com/psychedelic-...blossomanalysis.comPsychedelic Research Recap November 2024 - BlossomIn the November recap, we explore the neuroplasticity mechanisms of psychedelics, their therapeutic applications for mental health conditions. 020
blossomact.bsky.social @blossomact.bsky.social · 27/11/2024This theoretical framework paper analyzes two Phase III trials of MDMA-assisted therapy for PTSD, describing the conceptual underpinnings and therapeutic approach. 130
blossomact.bsky.social @blossomact.bsky.social · 21/11/20241) Collect and analyze the psychedelic research (and some consulting too) 2) Examining reimbursement of psychedelic therapies in Europe 3) Dune Prophecy just started ^^ 170
